1. Home
  2. VVOS vs CLDI Comparison

VVOS vs CLDI Comparison

Compare VVOS & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • CLDI
  • Stock Information
  • Founded
  • VVOS 2016
  • CLDI 2014
  • Country
  • VVOS United States
  • CLDI United States
  • Employees
  • VVOS N/A
  • CLDI N/A
  • Industry
  • VVOS Medical Specialities
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VVOS Health Care
  • CLDI Health Care
  • Exchange
  • VVOS Nasdaq
  • CLDI Nasdaq
  • Market Cap
  • VVOS 19.4M
  • CLDI 18.1M
  • IPO Year
  • VVOS 2020
  • CLDI N/A
  • Fundamental
  • Price
  • VVOS $5.02
  • CLDI $1.34
  • Analyst Decision
  • VVOS Strong Buy
  • CLDI Strong Buy
  • Analyst Count
  • VVOS 2
  • CLDI 3
  • Target Price
  • VVOS $6.30
  • CLDI $16.67
  • AVG Volume (30 Days)
  • VVOS 231.4K
  • CLDI 1.1M
  • Earning Date
  • VVOS 11-14-2024
  • CLDI 11-12-2024
  • Dividend Yield
  • VVOS N/A
  • CLDI N/A
  • EPS Growth
  • VVOS N/A
  • CLDI N/A
  • EPS
  • VVOS N/A
  • CLDI N/A
  • Revenue
  • VVOS $14,581,000.00
  • CLDI N/A
  • Revenue This Year
  • VVOS $12.35
  • CLDI N/A
  • Revenue Next Year
  • VVOS $26.02
  • CLDI N/A
  • P/E Ratio
  • VVOS N/A
  • CLDI N/A
  • Revenue Growth
  • VVOS 0.54
  • CLDI N/A
  • 52 Week Low
  • VVOS $1.91
  • CLDI $0.14
  • 52 Week High
  • VVOS $12.83
  • CLDI $3.89
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 60.64
  • CLDI 36.87
  • Support Level
  • VVOS $4.45
  • CLDI $1.27
  • Resistance Level
  • VVOS $5.12
  • CLDI $2.17
  • Average True Range (ATR)
  • VVOS 0.49
  • CLDI 0.19
  • MACD
  • VVOS 0.00
  • CLDI -0.09
  • Stochastic Oscillator
  • VVOS 55.33
  • CLDI 13.33

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Share on Social Networks: